Search
Search Results

No Search Results Found

LIVE
Search
Search Results

No Search Results Found

Explore HomeNewsPodcastsBreaking NewsSocial Watch Live Infowars NetworkThe Alex Jones ShowThe War Room with Owen ShroyerThe American Journal More Banned.VideoInfowars StoreArchiveRSSDownload Our App

Terms of Service

DMCA

Advertise with us

Affiliates

Media Inquiries

About

Featured

Internet AGAIN Admits “Alex Jones Was Right” After Newsweek Piece on Vampire-like Blood Transfusion Life Extension Technology

Infowars.com
April 8th 2021, 3:00 pm
'You know, I hate to admit it, but everyday that passes Alex Jones looks less crazy.'
Image Credit:
Infowars.com / Newsweek
Share
Share
Fund the InfoWar. Donate Now!
Keep up to date with our latest:
Email
Sign Up Now
Have an important tip? Let us know.Email us here.

Infowars’ Alex Jones trended once again on Twitter Wednesday, despite being banned from the social media platform.

Jones was already steadily rising up the trending charts after viral footage captured him physically stopping an illegal alien smuggling operation, but a Newsweek article on fountain of youth blood transfusions caused social media to explode with admissions Jones has been right about everything.

The piece, titled, “Can Blood from Young People Slow Aging? Silicon Valley Has Bet Billions It Will,” discusses various biotech companies experimenting with transplanting young blood into older patients in order to defy the aging process.

Earlier this year, Grifols closed on a $146 million-deal to buy Alkahest, a company founded by Stanford University neuroscientist Tony Wyss-Coray, who, along with Saul Villeda, revealed in scientific papers published in 2011 and 2014 that the blood from young mice had seemingly miraculous restorative effects on the brains of elderly mice. The discovery adds to a hot area of inquiry called geroscience that “seeks to understand molecular and cellular mechanisms that make aging a major risk factor and driver of common chronic conditions and diseases of older adulthood,” according to the National Institutes of Health. In the last six years, Alkahest has identified more than 8,000 proteins in the blood that show potential promise as therapies. Its efforts and those of Grifols have resulted in at least six phase 2 trials completed or underway to treat a wide range of age-related diseases, including Alzheimer’s and Parkinson’s.

Alkahest and a growing number of other geroscience health startups signal a change in thinking about some of the most intractable diseases facing humankind. Rather than focusing solely on the etiology of individual diseases like heart disease, cancer, Alzheimer’s and arthritis—or, for that matter, COVID-19—geroscientists are trying to understand how these diseases relate to the single largest risk factor of all: human aging. Their goal is to hack the process of aging itself and, in the process, delay or stave off the onset of many of the diseases most associated with growing old.

Following the article’s publication, many on social media admitted Jones was right about the topic he’d been covering for years.





















WATCH: Adrenochrome Ambrosia and how America Eats its Young

Share
FEATURED BANNED VIDEOS
In case you missed it...
Featured

Featured

Alex Jones Right Again: Scientists Admit They Successfully Created Human-Monkey Hybrids

posted 11 hours ago

Featured

New Alien Life Forms Created by Globalist Scientists

posted 11 hours ago

Featured

Biden Gives $530 Million No-Bid Contract To His Friends To Traffic And House Illegal Immigrants

posted 11 hours ago

Featured

BREAKING: O’Keefe to Sue Twitter Following Permanent Suspension

posted 12 hours ago

View More From Featured
Terms of ServiceDMCAAdvertise with usAffiliatesMedia InquiriesAbout